← Eichor
Study identifier: NCT06136195 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Influence of Mavoglurant on Alcohol Craving and Drinking in Heavy Drinkers

Condition: Alcohol Consumption · Heavy Drinker · Alcohol Use Disorder (AUD)  ·  Sponsor: Yale University

PhasePhase 1
Planned participants63
Who can joinAll sexes, 21 Years to 50 Years
Healthy volunteersNo

About this study

The purpose of this research study is to find out about the effects of a drug called mavoglurant on alcohol consumption.

This description comes directly from the study's public registry record.

Talk to the study team

Suchitra Krishnan, PhD  ·  203-974-7595  ·  suchitra.krishnan-sarin@yale.edu

Thomas Liss  ·  (203)974-7555  ·  thomas.liss@yale.edu

Always discuss trial participation with your own doctor first.

Locations (2)

Connecticut Mental Health Center (SAC and SATU)New Haven, Connecticut, United StatesRecruiting
Yale New Haven HospitalNew Haven, Connecticut, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06136195